drugset / Trial / NCT01124656
Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety and tolerability of pioglitazone-azilsartan, once daily (QD), in patients with type 2 diabetes mellitus.
Timeline
- Start
- 2006-09
- Primary completion
- 2007-05
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azilsartan | Unknown | 20 mg | Oral |
| Subject | Pioglitazone | Small molecule | 30 mg | Oral |
| Subject | Pioglitazone | Small molecule | 45 mg | Oral |